Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
International Journal of Family Medicine
|
April 11, 2014
Measuring staff empowerment regarding health care for clients with intellectual disabilities
Joanne Wilkinson, Nechama W Greenwood, Claire Tienwey Wang, et al.
Intellectual and Developmental Disabilities
|
April 15, 2014
Evaluating representativeness and cancer screening outcomes in a state department of developmental services database
Joanne Wilkinson, Emily Lauer, Nechama W Greenwood, et al.
European Journal of Gastroenterology & Hepatology
|
October 2, 2018
Randomized clinical trial: a double-blind, placebo-controlled study to assess the clinical efficacy and safety of alginate-antacid (Gaviscon Double Action) chewable tablets in patients with gastro-oesophageal reflux disease
Joanne Wilkinson, Alan Wade, S Jane Thomas, et al.
Journal of Digestive Diseases
|
September 14, 2016
Alginate antacid (Gaviscon DA) chewable tablets reduce esophageal acid exposure in Chinese patients with gastroesophageal reflux disease and heartburn symptoms
Yao Zong Yuan, Jing Yuan Fang, Duo Wu Zou, et al.
Scandinavian Journal of Gastroenterology
|
November 10, 2016
Psychometric evaluation of a daily gastro-oesophageal reflux disease symptom measure
Peter Bytzer, Christina Reimer, Gary Smith, et al.
Drug Development and Industrial Pharmacy
|
November 25, 2018
Two placebo-controlled crossover studies in healthy subjects to evaluate gastric acid neutralization by an alginate-antacid formulation (Gaviscon Double Action)
Joanne Wilkinson, Khalid Abd-Elaziz, Izaak den Daas, et al.
Contemporary Clinical Trials
|
June 7, 2021
Three week compared to seven week run-in period length and the assessment of pre-randomization adherence: A study within a trial
David Collister, Lawrence Mbuagbaw, Gordon Guyatt, et al.
The New England Journal of Medicine
|
April 5, 2016
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease
Eva M Lonn, Jackie Bosch, Patricio López-Jaramillo, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
International Journal of Family Medicine
|
April 11, 2014
Measuring staff empowerment regarding health care for clients with intellectual disabilities
Joanne Wilkinson, Nechama W Greenwood, Claire Tienwey Wang, et al.
Intellectual and Developmental Disabilities
|
April 15, 2014
Evaluating representativeness and cancer screening outcomes in a state department of developmental services database
Joanne Wilkinson, Emily Lauer, Nechama W Greenwood, et al.
European Journal of Gastroenterology & Hepatology
|
October 2, 2018
Randomized clinical trial: a double-blind, placebo-controlled study to assess the clinical efficacy and safety of alginate-antacid (Gaviscon Double Action) chewable tablets in patients with gastro-oesophageal reflux disease
Joanne Wilkinson, Alan Wade, S Jane Thomas, et al.
Journal of Digestive Diseases
|
September 14, 2016
Alginate antacid (Gaviscon DA) chewable tablets reduce esophageal acid exposure in Chinese patients with gastroesophageal reflux disease and heartburn symptoms
Yao Zong Yuan, Jing Yuan Fang, Duo Wu Zou, et al.
Scandinavian Journal of Gastroenterology
|
November 10, 2016
Psychometric evaluation of a daily gastro-oesophageal reflux disease symptom measure
Peter Bytzer, Christina Reimer, Gary Smith, et al.
Drug Development and Industrial Pharmacy
|
November 25, 2018
Two placebo-controlled crossover studies in healthy subjects to evaluate gastric acid neutralization by an alginate-antacid formulation (Gaviscon Double Action)
Joanne Wilkinson, Khalid Abd-Elaziz, Izaak den Daas, et al.
Contemporary Clinical Trials
|
June 7, 2021
Three week compared to seven week run-in period length and the assessment of pre-randomization adherence: A study within a trial
David Collister, Lawrence Mbuagbaw, Gordon Guyatt, et al.
The New England Journal of Medicine
|
April 5, 2016
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease
Eva M Lonn, Jackie Bosch, Patricio López-Jaramillo, et al.
Page
of 2